课题基金 / 基金详情

Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis

Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
FBXO45 在弥漫性大 B 细胞淋巴瘤发病机制中的作用
批准号:
9817011
负责人:
KOJO S. J. ELENITOBA-JOHNSON
金额:
$50.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-03 至 2024-06-30

项目摘要

项目成果

KOJO S. J. ELENITOBA-JOHNSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY THE ROLE OF FBXO45 IN DIFFUSE LARGE B-CELL LYMPHOMA PATHOGENESIS Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma and represents the most common form of malignant lymphoma in the western hemisphere. The biologic events underlying the pathogenesis of DLBCL are not completely understood. We have recently identified functional inactivation of FBXO45, an E3 ubiquitin ligase in DLBCL. In this application, we will utilize transgenic mouse models to explore the biological roles for FBXO45 in B-cell differentiation and lymphomagenesis. Further, we will employ biochemical and molecular biology techniques to better understand the role FBXO45 in the pathogenesis of DLBCL. Accordingly, we propose in the first aim of this application to utilize newly created transgenic mouse models to functionally interrogate the role of FBXO45 in B- cell development and lymphomagenesis. In the second aim, we will identify the global cellular substrates of FBXO45 in B cell contexts. These studies will establish the role of FBXO45 in the pathogenesis of DLBCL and establish the mechanisms by which its deregulation contributes to DLBCL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
  • 批准号:
    10655478
  • 项目类别:
  • 资助金额:
    $53.08万
  • 财政年份:
    2022
  • 负责人:
    KOJO S. J. ELENITOBA-JOHNSON
  • 依托单位:
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
  • 批准号:
    10703746
  • 项目类别:
  • 资助金额:
    $51.11万
  • 财政年份:
    2022
  • 负责人:
    KOJO S. J. ELENITOBA-JOHNSON
  • 依托单位:
Genomic biomarkers of splenic lymphoma
  • 批准号:
    10703846
  • 项目类别:
  • 资助金额:
    $19.45万
  • 财政年份:
    2022
  • 负责人:
    KOJO S. J. ELENITOBA-JOHNSON
  • 依托单位:
Genomic biomarkers of splenic lymphoma
  • 批准号:
    10531857
  • 项目类别:
  • 资助金额:
    $62.15万
  • 财政年份:
    2022
  • 负责人:
    KOJO S. J. ELENITOBA-JOHNSON
  • 依托单位:
海外基金